Rebirth: Super Banking System Chapter 2405 - 2245: The United States Introduces Transcription Fluid
Previously on Rebirth: Super Banking System...
The 21st.
Morning hours.
A major announcement swept through the global media.
In the United States.
Officials declared the official rollout of Transcription Fluid within the national health framework. Starting from August, citizens across the country could access care at twelve designated hospitals nationwide.
All at once.
Excitement gripped the United States.
After three years.
It had taken a complete three years to finally bring in Transcription Fluid. Countless Americans rejoiced, even though trips to Myanmar weren't too costly and offered chances for some sightseeing.
Still.
Why spend if you can avoid it.
Plus.
In the past, treatments in Myanmar meant full personal payments, forcing many Americans to take loans for it. With insurance now covering costs, it truly aided a large number of folks.
Take those in poverty.
In the United States.
Poverty exists too, and it's widespread. They don't go hungry, but even a flight ticket is out of reach for many. This has held back plenty of people.
Today.
Hope finally breaks through.
...
Meanwhile.
Elsewhere.
Leading U.S. pharmaceutical firms experienced a sharp wave of irritation.
Earlier.
The delays in approving Transcription Fluid were mostly about grabbing some bargaining power, but it turned out to be nearly useless, while the opponents raked in extra gains.
Tourism.
Purchases.
Ventures.
...
They generated massive earnings overall. Data showed that in recent years, American visits to Myanmar for care had driven billions in spending.
As a result.
Their roadblocks proved pointless. For ongoing illnesses, there's room to highlight dangers since they don't kill right away, allowing warnings about procedure hazards.
But.
Cancer strikes at the core of survival.
So.
When staring down death, folks ignore every so-called danger, flocking there for extra time, even if just a couple of years—anything beats the grave right now.
On top of that.
Based on observed results, it's not merely a few years; decades could be on the table.
...
Out of options.
They could barely pressure the opposition.
Even worse.
Years of Transcription Fluid studies yielded zero breakthroughs, and tests revealed benefits for additional conditions too.
Such as.
Radiation-induced cancers.
Back then.
Overexposure to radioactive materials was basically fatal. Survivors often stayed frail, with potential genetic harm.
Yet.
Transcription Fluid managed to curb those alterations.
To sum up:
---Plunge into nuclear waste without fear.
That moment.
Scientists were utterly stunned!
Holy hell!
Could this be some miracle cure? They dreamed of sending warships to claim the tech outright, but the world didn't bend that way.
Endless barriers.
Trying to steal it.
No luck at all—every agent sent got nabbed, bringing back zilch. Internal sabotage efforts flopped completely, without even a tiny breach.
Compounded by internal disagreements in the alliance.
They had to back off.
...
Afterward.
Things calmed for a period. But last year, the emergence of Alzheimer's treatments showed their rivals' strong pharma prowess.
Right away.
The financial hit topped a hundred billion dollars.
Deeply alarmed.
Still.
They stood helpless, as public pressure forced U.S. leaders to greenlight the rollout fast. Several pharma giants saw this as payback from the other party.
Over two years.
You blocked our meds.
Fine.
We'll smash your profits.
Let's see who boils over first.
Because of this.
They held meetings, speeding up Transcription Fluid's approval to mend ties with Myanmar’s Pharmaceutical Group—they were scared for real.
That way.
When the next game-changing drug appears, they might get a heads-up instead of a sneaky undercut.
It stings!
...
As soon as the announcement hit, nations worldwide grew restless.
The United States.
Being the current dominant power, its actions draw eyes from everywhere, with many nations following its example.
Hence.
During these three years.
Few countries actually rolled out Transcription Fluid. The Western bloc largely watched and waited, except for those pushed to the limit.
Such as India.
Which embraced it with zeal.
They had no alternative.
Being neighbors.
With a struggling economy, scarce forex reserves, and lingering debts, bringing it in cut huge costs in currency outflows.
Thus.
Their eagerness.
The rest.
Held back, wary of fallout without U.S. backing.
Now.
Witnessing the U.S. yield, validating Transcription Fluid's power and fast-tracking it, others jumped on board without delay.
---Rolling it out.
Before long.
The globe buzzed with activity.
...
In Myanmar.
Inside the capital city.
"Ha!"
"It's truly... neither great nor terrible news." Kan Qin glanced at the report and laughed lightly; he wasn't learning this from the broadcast alone.
Naturally.
With the U.S. set to treat patients from August, how could late July arrive without prior talks with the suppliers? Contacts started in late June.
Endless negotiations.
Back-and-forth chats.
They wrapped up key points after nearly two weeks, then went public with rollout plans. Diagnostic units, operating gear, and loads of Transcription Fluid.
Were already en route by ship.
In three days.
Set to dock in the U.S., while training physicians is straightforward—though the U.S. skipped Transcription Fluid domestically, it doesn't mean their medics are clueless.
Previously.
Even outside U.S. soil.
Still.
Plenty of international aid clinics exist, packed with American docs at those sites; grabbing a few dozen would cover it.
More than enough.
No other way.
With medical automation, especially for cancers, one doc handles tons of cases—mostly for show.
Hands-on know-how?
Unnecessary.
...
To be honest.
Kan Qin doesn't sweat the U.S. adopting Transcription Fluid or not; skipping it means more tourist bucks. Sure, adoption is fine too.
It just cuts earnings a touch.
Also.
In the near future.
Myanmar's visitor industry stays robust, thanks to years of growth in travel setups and attractions.
Featuring uniques unavailable anywhere else.
- Xin’an City.
Full-city holograms, a one-of-a-kind spectacle, now a global hotspot for travelers.
- Delin Province.
A hundred miles of premium coastal retreats, turned into a top vacation spot.
- Museums.
One stop for worldwide wonders, all 'replicas' but in huge numbers! Massive dino replicas, a hall of hundred-ton gold, dazzling diamond exhibits.
Plus stacks of cash mountains totaling billions.
And.
Loads of other key sites worth visiting.
At the same time.
Through Transcription Fluid and other life-saving innovations, Myanmar boosted its image worldwide, pulling in crowds like never before.
Boosted by those arriving for cures, spreading the word.
So.
Pure leisure visitors keep coming strong; per the figures, tourism holds up even without the medical crowd.
That's.
Why he calls it 'neither great nor terrible.'
He's long endorsed Gold's view: "Drawing crowds just for cures shows weakness."